Capecitabine is an orally administered chemotherapeutic agent within the fluoropyrimidine class, primarily utilized to treat breast, colon, and rectal cancers by inhibiting DNA synthesis and cell proliferation.… Read more
![Chemical structure of ((3aR,4R,6aR)-6-Methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methanol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F72402-14-3-3aR4R6aR-6-Methoxy-22-dimethyltetrahydrofuro34-d13dioxol-4-ylmethanol.png&w=3840&q=75)








![Chemical structure of (3aR,4R,6R,6aR)-2,2,6-Trimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F132064-84-7-3aR4R6R6aR-226-Trimethyltetrahydrofuro34-d13dioxol-4-ol.png&w=3840&q=75)
![Chemical structure of (3aR,4S,6R,6aR)-4-Chloro-2,2,6-trimethyltetrahydrofuro[3,4-d][1,3]dioxole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F316166-19-5-3aR4S6R6aR-4-Chloro-226-trimethyltetrahydrofuro34-d13dioxole.png&w=3840&q=75)









![Chemical structure of 2’,3’-Di-O-acetyl-5’-deoxy-5-fluoro-N-[(3-methylbutoxy)carbonyl]cytidine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F162204-22-0-23-Di-O-acetyl-5-deoxy-5-fluoro-N-3-methylbutoxycarbonylcytidine.png&w=3840&q=75)









![Chemical structure of 5’-Deoxy-5-fluoro-N, N-di-[(pentyloxy)carbonyl]cytidine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F5-Deoxy-5-fluoro-N-N-di-pentyloxycarbonylcytidine.png&w=3840&q=75)



















Capecitabine is an orally administered chemotherapeutic agent within the fluoropyrimidine class, primarily utilized to treat breast, colon, and rectal cancers by inhibiting DNA synthesis and cell proliferation. To support rigorous quality control and pharmaceutical research, this category provides a comprehensive range of Capecitabine reference standards, including pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope-labelled compounds. These materials are essential for pharmaceutical laboratories conducting impurity profiling, method validation, and analytical method development. Researchers rely on these high-quality standards for the accurate identification of related substances during batch release testing and forced degradation studies, ensuring compliance with global regulatory frameworks such as those set by the FDA and the European Pharmacopoeia. Utilizing these precisely characterized compounds facilitates consistent and reliable analytical outcomes throughout the drug development and manufacturing lifecycle.